Funded Tech Companies

NeuCyte

Researching who invested in NeuCyte? Cowin Venture Capital, private investors and Leaguer Ventures joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
NeuCyte
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
1561 Industrial Rd.
San Carlos, CA 94070
USA
Email Address

Company Background Information

Overview
The high attrition rates of novel CNS drugs in clinical trials is a clear indication that current drug discovery paradigms are failing to serve the unmet needs of millions of patients. Our mission is to improve the lives of these individuals by developing better translatable assays to accelerate and optimize CNS drug discovery.
Profile
NeuCyte LinkedIn Company Profile
Social Media
NeuCyte Company Twitter Account
Company News
NeuCyte News
Facebook
NeuCyte on Facebook
YouTube
NeuCyte on YouTube
Last Transaction
5/9/2018

Financing History

Date
Type
Amount
Venture Equity
$6,700,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Tao Huang
  Tao Huang LinkedIn Profile  Tao Huang Twitter Account  Tao Huang News  Tao Huang on Facebook
Chief Scientific Officer
Daniel Haag
  Daniel Haag LinkedIn Profile  Daniel Haag Twitter Account  Daniel Haag News  Daniel Haag on Facebook
VP - Operations
Ji Wu
  Ji Wu LinkedIn Profile  Ji Wu Twitter Account  Ji Wu News  Ji Wu on Facebook
VP - R & D
Thomas Portman
  Thomas Portman LinkedIn Profile  Thomas Portman Twitter Account  Thomas Portman News  Thomas Portman on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Neuchips | Neudata

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary